Biologics Keep Early RA in Check for at Least 1 Year

(MedPage Today) -- Treatment with at least some biologic drugs significantly reduced 1-year progression of early rheumatoid arthritis (RA) relative to classical small-molecule agents, researchers reported. Patients assigned to certolizumab pegol...
Source: MedPage Today Rheumatology - Category: Rheumatology Source Type: news